US Bancorp’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-567
Closed -$3K 4265
2022
Q2
$3K Hold
567
﹤0.01% 3778
2022
Q1
$5K Hold
567
﹤0.01% 3642
2021
Q4
$7K Sell
567
-128
-18% -$1.53K ﹤0.01% 3563
2021
Q3
$8K Buy
+695
New +$7.84K ﹤0.01% 3537

Other funds holding SLGC

US Bancorp's SLGC Position: Q3 2022 in Review

US Bancorp sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2022, closing a stake of 567 shares — an estimated $3K sold.

US Bancorp first reported a position in SLGC in Q3 2021 and held it in 4 quarters. The position peaked at $8K in Q3 2021. 126 funds tracked by Wall St. Rank hold SLGC as of Q3 2022.

  • US Bancorp reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • US Bancorp sold 567 SomaLogic, Inc. Class A Common Stock shares in Q3 2022, an estimated $3K.
  • US Bancorp first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 4 quarters.
  • US Bancorp's SomaLogic, Inc. Class A Common Stock position peaked at $8K in Q3 2021.
  • 126 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2022.

Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.